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Introduction
As the older adult population has increased, the age of liver transplantation (LT) recipients has increased steadily over the past two decades in Korea and throughout the world. However, the debate regarding allocation of scarce donor organs to older patients has continued because advanced patient age is associated with higher risks of infection and cardiovascular disease that can become life-threatening after transplantation (1) (2) (3) . Nevertheless, because the life expectancy of people worldwide is getting longer, the number of older patients requiring LT is expected to increase.
Since the first living donor LT (LDLT) and deceased donor LT (DDLT) in patients aged >60 years at the Asan Medical Center in 1998, the proportion of LT recipients >60 years of age has steadily increased from 1.9% in 2000 to 22.4% in 2015 . With the accumulation of >4000 cases of LDLT with advances in surgical techniques and perioperative medical intensive care for LT patients, we have expanded the recipient pool of those who need LT to include patients in their late 70s. The number of LT recipients aged ≥70 years has been increasing since 2010 ( Figure 1 ).
As the number of older LT recipients has increased, the importance of knowing the risks and potential outcomes of LT for older patients has been increasingly emphasized. Several articles involving older recipients have been published (4) (5) (6) (7) (8) (9) (10) ; however, there is still no clear-cut age limit for LT recipients, and most articles described experiences with DDLT with very few exceptions. The main aims of this study were to review our experiences with patients aged ≥70 years at the time of transplantation and to investigate the feasibility of LDLT.
Materials and Methods

Study design and patient population
Our institutional LT database was searched to identify LT recipients who underwent LT at age ≥70 years. A total of 59 liver failure patients aged ≥70 years were referred to our department for transplantation from January 2000 to April 2016; 25 patients (15 LDLT and 10 DDLT recipients) aged ≥70 years had undergone LT during that period.
During the same period, 572 LT were performed for sexagenarians. For comparison, we performed 1:3 individual matching between the 70-yearold patient group (patients aged ≥70 years) and the 60-year-old group (patients aged 60-69 years). Finally, 25 patients and 73 patients were included in each group after matching. We retrospectively reviewed and analyzed the clinical course of those patients.
Indication for LT and donor selection
The LT indications and contraindications for patients ≥70 years were nearly identical to those for patients <70 years. However, for a candidate who was ≥70 years, our institute had the following exclusion criteria for LT: use of two or more vasopressors or inotropics, organ failure other than liver and kidney (for heart failure, patients with New York Heart Association class II or higher), hepatocellular carcinoma (HCC) unfulfilled Milan criteria, and grade 4 using American Society of Anesthesiologists (ASA) or Eastern Cooperative Oncology Group (ECOG) criteria.
Indications for LT for patients ≥70 years consisted of decompensated Child-Turcotte-Pugh class B or C cirrhosis and concurrent complications of portal hypertension with or without HCC; these indications are the same as those for patients <70 years. Indications for LDLT and DDLT were almost the same; however, for a candidate ≥70 years of age, patients with a Model for End-Stage Liver Disease (MELD) score >25 were excluded from being eligible for LDLT and were on standby for DDLT according to the allocation policy of the Korean Network for Organ Sharing. In addition, patients who met grade 4 ASA or ECOG criteria were excluded from LT, but DDLT was considered in these patients with good performance status before admission, that is, before the rapid deterioration of condition due to portal hypertension.
The selection criteria and evaluation process for living liver donors for septuagenarian candidates were not much different from what we have Figure 1 : Change in the rate of liver transplant recipients older than 60 and 70 years annually. The percentage of liver transplant recipients older than 60 and 70 years is increasing steadily. The number of total adult liver transplant cases and recipients aged ≥70 years are marked. [Color figure can be viewed at wileyonlinelibrary.com] described elsewhere (11, 12) . However, for a candidate ≥70 years of age, the estimated volume of the graft had to satisfy a minimum graft-torecipient weight ratio (GRWR) of 1.0% and graft volume to the recipient's standard liver volume (GV/SLV) of 50%. Although not achieved in every case, we preferred a donor aged <35 years.
Pre-LT evaluation
To preoperatively evaluate cardiovascular comorbidities, echocardiography, coronary computed tomography (CT) angiography, and thallium scan of myocardial perfusion were performed for all recipients before LT except in cases of high-urgency DDLT. In addition, pulmonary function test and brain magnetic resonance angiography were performed for all recipients before LT. All patients were referred to the relevant department, and the risk of surgery was evaluated.
The operative risk for all recipients was assessed by anesthesiologists according to the ASA physical status classification system (13) . Patients were also classified from grade 0 to 5 based on ECOG performance status (14) .
Surgical technique and immunosuppressants
Surgical procedures for LDLT, including dual-graft (DG) LDLT, were described in detail elsewhere (15) (16) (17) (18) . We have routinely used a conventional inferior vena cava interposition technique for DDLT. The immunosuppression regimen was the same as that for young adult LT recipients and consisted of anti-IL-2 (basiliximab) induction therapy and tacrolimus-based therapy in combination with mycophenolate mofetil and a course of prednisolone for <3 mo. However, we used 60% to 80% of the tacrolimus dosage for those <70 years, and the corticosteroid dose was adjusted on a case-by-case basis to minimize the risk of infection. 
Statistical analysis
Ethical considerations
This study protocol was approved by the institutional review board of the Asan Medical Center (approval number 2016-1303), University of Ulsan College of Medicine, Seoul, Korea. The requirement for informed consent was waived because of the retrospective nature of the study.
Results
Experience with LDLT in patients aged ≥70 years Recipient and donor baseline characteristics: During the study period, LDLT was performed for 15 patients (single graft implantation in 10, DG implantation in five Six patients experienced a total of seven complications, and the morbidity rate for patients aged ≥70 years who underwent LDLT was 40.0%. In terms of surgical complications, there was postoperative bleeding (n = 1) that required exploration and hematoma evacuation under general anesthesia and anterior segment congestion of the graft (n = 1) that came from obstruction of interposition vein graft draining segments 5 and 8. Medical complications included HCV reactivation (n = 2), disseminated tuberculosis (n = 1), biopsy-proven acute cellular rejection (n = 1), and sepsis due to pneumonia (n = 1).
Regarding in-hospital mortality, three (20%) LDLT recipients died. One was a 76-year-old man with toxic hepatitis and fulminant hepatic failure who underwent LDLT using a left lobe graft from his 42-year-old son; the GRWR was 0.83%. The patient recovered well immediately after surgery but was readmitted to the ICU on postoperative day 8 because of respiratory failure. At 1 mo postoperatively, unexpected bleeding requiring exploration occurred at the abdominal drain catheter insertion site. After surgery, the bleeding was resolved and his preexisting pneumonia deteriorated; the patient died of septic shock 1 day after exploration. The second patient was a 72-year-old man with HCV-associated liver cirrhosis and HCC who underwent salvage LDLT with a modified right lobe graft from his 43-year-old daughter; GRWR was 1.24%. Six days after LT, the blood test showed abnormal findings of increased liver enzymes, and the CT scan revealed thrombus on the reconstructed middle hepatic vein graft, which resulted in severe congestion of the anterior segment of the graft. This anterior segment congestion reduced the functional liver volume and resulted in symptoms similar to those that occur when a graft that is too small is used. Finally, progressive graft dysfunction led to septic complications, and the patient died of pneumonia. The cause of death for the third patient was low-dose immunosuppressant-induced refractory acute rejection, which resulted in graft failure. The mean survival time was 45.0 AE 6.4 mo. The overall 1-and 5-year patient and graft survival rates for recipients aged ≥70 years were 80.0% and 68.6%, respectively. There were no significant differences in this result when compared with our DDLT results (p = 0.869 for patient survival and p = 0.762 for graft survival). The graft and overall patient survival rates for LDLT and DDLT are shown in Figure 2 . The morbidity and mortality of the 20 living donors included in this study were both 0%.
DDLT experience for patients aged ≥70 years Ten DDLTs were performed for septuagenarians during the study period. The demographic features and operative details of the patients are presented in Four patients experienced morbidity after DDLT, as follows: biopsy-proven acute cellular rejection, spontaneous pneumothorax, a biliary stricture that required interventional biliary endoscopy, and sepsis. One patient died without recovering from sepsis. The morbidity rates and in-hospital mortality rates for patients aged ≥70 years who underwent DDLT were 40.0% and 10.0%, respectively. The 1-and 5-year graft survival rates for these recipients were 80.0% and 60.0%, respectively. Otherwise, the mean survival time was 45.8 AE 8.6 mo, and the overall 1-and 5-year patient survival rates for recipients aged ≥70 years were 90.0% and 67.5%, respectively.
Comparison of LT outcomes for the 60-and 70-yearold groups
When comparing the 70-year-old patient group with the 1:3 matched 60-year-old group, significant differences were observed in the presence of intractable ascites, the number of patients who stayed in the ICU before LT, and donor age. The 70-year-old group had intractable ascites more frequently than the 60-year-old group (p = 0.002), and more patients aged ≥70 years received preoperative ICU treatment (p = 0.028). The length of postoperative hospital stay was longer for the 70-yearold group (p = 0.011). Demographic features and clinical outcomes are compared and summarized in Tables 3  and 4 .
The graft and overall patient survival rates of the 70-and 60-year-old groups are shown in Figure 3 . There were no statistically significant differences in the 1-and 5-year patient and graft survival rates between groups (p = 0.372 and p = 0.183, respectively).
Discussion
Due to life extension, the older adult population has increased worldwide in recent decades, and the burden of liver disease in patients of advancing age has also increased (19) . In accordance with this trend, LT, which has been considered standard therapy for end-stage liver disease, is being extended to older patients. Beginning in 1998, our institution expanded the pool of transplant recipients to include persons previously considered ineligible because of advanced age. Although there has been some controversy regarding feasibility and concern about poor outcomes of LT for patients of old age, LT has been performed for selected patients aged ≥70 years because of advances in surgical techniques, anesthesia, and critical care for recipients.
In the present study, even though the septuagenarians had more portal hypertension symptoms than sexagenarians, LDLT for septuagenarians had comparable and acceptable mortality and morbidity rates compared with sexagenarians. DDLT involves an easy surgical technique and provides sufficient graft volume, but there is controversy regarding allocating the deceased donor graft because evidence is lacking for patients of very advanced age, especially in countries that lack deceased donors. Although there is no age limit for undergoing DDLT according to the allocation policy of the Korean Network for Organ Sharing, for older patients, our institution prefers LDLT without the use of public resources if the patient status is included in our indications for LDLT. In countries that lack organs from deceased donors, our patient selection algorithm based on our experience, presented in Figure 4 , and the reasonable outcomes of LDLT are believed to be meaningful results that can be used as a guide for the treatment of older patients who require LT.
Because of ethical issues associated with surgical risk for healthy living liver donors, decisions for LT in these patients must be made carefully. The initial outcome of LDLT in septuagenarians at our institution was not satisfactory. Until 2010, only two LDLTs for 70-year-old patients had been performed; neither patient was able to recover, and both died after surgery. These two patients account for two-thirds of the in-hospital mortality of LDLT septuagenarians at our institution. Growing concern regarding outcomes of LT for septuagenarians has led to an increased focus on the selection of both candidate recipients and donors. Since 2011, the outcomes of LDLT for septuagenarians have markedly improved with reasonable patient selection. It is well known that graft quality (including graft size, steatosis, and donor age) and recipient condition (including patient performance status, MELD score, and severity of portal hypertension) are determinants of recipient outcomes (20) . Similar to previous studies of older LT recipients, our experience showed that the MELD score is one of the important factors influencing the outcomes of LT for septuagenarians (6-9). In our series, two of the three septuagenarian LDLT patients who died had Child-Turcotte-Pugh scores >10 and MELD scores >20. Kenneth et al (21) reported that the short-and long-term outcomes of LDLT can be comparable with those of DDLT, even for patients with ultrahigh MELD scores; however, based on the experience of our center, we prefer to perform DDLT for septuagenarians with MELD scores >25, except when imminent death is inevitable.
Selection of a suitable donor is very important for successful LDLT. There are many studies and opinions regarding the criteria for donor selection. Although controversial, a GRWR of 0.8% is currently recognized as the safe limit to avoid small-for-size grafts, and potential donors for right-lobe hepatectomy are generally confined to healthy volunteers aged <55 years (22) (23) (24) . Depending on the recipient and graft conditions, however, donor selection criteria may need to be changed. At our center, as in others, donors for patients aged ≥70 years are more carefully selected (3, 25) . Liver grafts from young donors with sufficient GRWR can tolerate posttransplant surgical and medical complication well. LDLT for 70-year-old patients requires an estimated graft volume >1.0% of the GRWR or >50% of the GV/SLV at our institution. Regarding donor age, some reports have suggested that the function and regeneration of allografts from aged donors for LDLT were worse than those of younger counterparts (26) (27) (28) . It is difficult to describe an absolute age, but we prefer to use living donors aged <35 years for patients aged ≥70 years. In actual practice, however, the choice of living donors is often limited, and it may not be possible to find an adequate graft in all cases. Because most donors are children of the recipients, as shown in Table 2 , the donors for 70-year-old patients are relatively older. To reduce the risks of complications for the relatively older donor and to provide a graft of adequate volume that meets the patient's metabolic requirements, DG LDLT has been performed for selected patients aged ≥70 years.
At our institution, since the first successful DG LDLT in 2000, >400 patients have undergone DG LDLT and achieved successful results (16) (17) (18) . Despite significant experience with DG LDLT, careful consideration was given before implementing DG LDLT for patients ≥70 years of age because DG LDLT demands complex surgical techniques and longer operative time. Furthermore, in our previous study, risk factor analysis for survival revealed that advanced recipient age is a significant variable (18) . Nevertheless, there is a consensus in the transplant society that biological and physiological variables have a more important role than advanced age in predicting survival after LT (8) . In addition, experiences have taught us that even if the surgery takes a long time, preventing surgical complications by using meticulous surgical techniques is a key factor for good clinical outcomes. Consequently, wellselected patients aged ≥70 years should not be excluded from consideration for DG LDLT because of their age. Older patients with chronic liver diseases and reduced ability to maintain homeostasis from physiological changes could be susceptible to several complications by the addition of immunosuppressants after LT. In particular, because advancing age is related to weakened immune function and probable increased susceptibility to infection, overimmunosuppression could be fatal for older recipients (29) . Infections and cancers associated with lower immune function contribute more to mortality than rejection after transplantation (30) (31) (32) . As our results show, however, rejection can also cause in-hospital mortality. Overall, immunosuppressants should be used carefully and should be tailored to each patient depending on the specific clinical requirements and risk factors.
Appropriate general perioperative management strategies are important to optimize outcome. Preoperative comorbidities and physical conditions are important factors that increase the risk of surgery. The preoperative evaluation should be performed for the whole body, and, if possible, LT should be performed after the treatment of other medical problems. Perioperative cardiovascular complications are a major cause of posttransplant morbidity and mortality, especially for older patients; therefore, meticulous cardiovascular evaluations are required to assess perioperative risks and to prevent concomitant cardiovascular complications (33) . Although a gold standard has not yet been developed for cardiac evaluation of candidates for LT, we performed echocardiography, coronary CT (angiography), and thallium scan of myocardial perfusion to evaluate cardiac function and coronary heart disease. In cases of abnormal findings, coronary angiography or cardiac catheterization was performed for further evaluation. In addition, during surgery, our anesthesiologist confirmed the dynamic cardiac function, volume status, contractility, and regional wall motion in real-time using intraoperative transesophageal echocardiography (34) . In addition to cardiovascular evaluations, because adequate nutritional support for patients undergoing major surgery significantly affects postoperative recovery, a nutritional assessment should be performed to confirm nutritional status; then, the appropriate measures should be taken (35, 36) . At our institution, when an LT candidate is classified as malnourished, an enteral feeding tube is inserted before LT to correct the nutritional status. In addition, for proper nutrition support after surgery, feeding jejunostomy is performed during the LT for patients who are expected to be unable to eat for a long period after transplantation (37) . Most important, the occurrence of complications during postoperative care should be detected early, and subsequent intervention should be performed through a multidisciplinary approach by the surgical, radiological, medical, and anesthesia teams.
The present study had limitations such as the relatively small sample size, short follow-up period, and retrospective study design. Nevertheless, the results of this study are meaningful because it included the largest number of septuagenarian LDLT recipients with end-stage liver disease to date. This study even included the results of DG LDLT for patients aged ≥70 years, which have not been reported before.
In conclusion, LT for well-selected septuagenarians has acceptable mortality and morbidity. Our experience suggests that patients ≥70 years of age should not be excluded from undergoing LT or even LDLT based on chronological age. Careful selection of recipients and donors as well as meticulous surgical techniques are necessary for successful results.
